Clinician satisfaction and insertion characteristics of a new applicator to insert radiopaque Implanon: An open-label, noncontrolled, multicenter trial

Contraception

Volumn 82, Issue 3, 2010, Pages 243-249

  Mansour, Diana ^a   Mommers, Ellen ^b   Teede, Helena ^c   Sollie Eriksen, Bjarne ^d   Graesslin, Oliver ^e   Ahrendt, Hans Joachim ^f   Gemzell Danielsson, Kristina ^g  

^a Newcastle and North Tyneside Health Authority   (United Kingdom)

^b Division of Merck and Co   (Netherlands)

^c MONASH UNIVERSITY   (Australia)

^d Haugesund Gyn Klinikk   (Norway)

^e Institut Mère Enfant Alix de Champagne   (France)

^f Klinische Forschung und Weiterbildung   (Germany)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Contraceptive implant; Etonogestrel; Implanon; Long acting reversible contraceptives

Indexed keywords

ETONOGESTREL;

ADULT; AGED; APPLICATION SITE PAIN; APPLICATION SITE REACTION; APPLICATION SITE SWELLING; ARTICLE; CLINICAL TRIAL; FEMALE; HEMATOMA; HUMAN; IMPLANTATION; MEDICAL INSTRUMENTATION; NEEDLE; NORMAL HUMAN; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; QUESTIONNAIRE; RADIOGRAPHY; SATISFACTION; SKIN; SKIN REDNESS;

ADOLESCENT; ADULT; CONTRACEPTION; DESOGESTREL; FEMALE; HUMANS; PERSONAL SATISFACTION; PHYSICIANS; QUESTIONNAIRES; YOUNG ADULT;

EID: 77955587297     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.04.007     Document Type: Article

References (14)

1. Etonogestrel implant (Implanon) for contraception Drug Ther Bull 39 2001 57 59
2. Blumenthal P.D., Gemzell-Danielsson K., and Marintcheva-Petrova M. Tolerability and clinical safety of Implanon Eur J Contracept Reprod Health Care 13 Suppl 1 2008 29 36
3. Lipetz C., Phillips C., and Fleming C. Actual cost of providing long-acting reversible contraception: a study of Implanon cost J Fam Plann Reprod Health Care 35 2009 75 79
4. Lipetz C., Phillips C.J., and Fleming C.F. The cost-effectiveness of a long-acting reversible contraceptive (Implanon) relative to oral contraception in a community setting Contraception 79 2009 304 309
5. Graesslin O., and Korver T. The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience Eur J Contracept Reprod Health Care 13 Suppl 1 2008 4 12
6. Makarainen L., van Beek A., Tuomivaara L., Asplund B., and Coelingh Bennink H. Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant Fertil Steril 69 1998 714 721
7. Wenzl R., van Beek A., Schnabel P., and Huber J. Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon Contraception 58 1998 283 288
8. Mansour D., Korver T., Marintcheva-Petrova M., and Fraser I.S. The effects of Implanon on menstrual bleeding patterns Eur J Contracept Reprod Health Care 13 Suppl 1 2008 13 28
9. Shulman L.P., and Gabriel H. Management and localization strategies for the nonpalpable Implanon rod Contraception 73 2006 325 330
10. Schnabel P., Mommers E., and Marintcheva-Petrova M. Bioequivalence and X-ray visibility of radiopaque etonogestrel implant and Implanon® Presented at The 8th Congress of the European Society of Gynecology, September 10-13, 2009, Rome, Italy 2009
11. Levine J.P., Sinofsky F.E., and Christ M.F. Assessment of Implanon insertion and removal Contraception 78 2008 409 417
12. Harrison-Woolrych M., and Hill R. Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia Contraception 71 2005 306 308
13. Singh M., Mansour D., and Richardson D. Location and removal of non-palpable Implanon implants with the aid of ultrasound guidance J Fam Plann Reprod Health Care 32 2006 153 156
14. Mansour D., Fraser I.S., and Walling M. Methods of accurate localisation of non-palpable subdermal contraceptive implants J Fam Plann Reprod Health Care 34 2008 9 12